Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage

Cerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in elderly patients. Growing evidence suggests a potential role of aquaporin 4 (AQP4) in amyloid-beta-associated diseases, including CAA pathology. Our aim was to investigate the circulating levels of AQP4 in...

Full description

Bibliographic Details
Main Authors: Paula Marazuela, Anna Bonaterra-Pastra, Júlia Faura, Anna Penalba, Jesús Pizarro, Olalla Pancorbo, David Rodríguez-Luna, Carla Vert, Alex Rovira, Francesc Pujadas, M. Mar Freijo, Silvia Tur, Maite Martínez-Zabaleta, Pere Cardona Portela, Rocío Vera, Lucia Lebrato-Hernández, Juan F. Arenillas, Soledad Pérez-Sánchez, Joan Montaner, Pilar Delgado, Mar Hernández-Guillamon
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/5/989
id doaj-d7ced31b16e942579a4c22a7ac4a3261
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Paula Marazuela
Anna Bonaterra-Pastra
Júlia Faura
Anna Penalba
Jesús Pizarro
Olalla Pancorbo
David Rodríguez-Luna
Carla Vert
Alex Rovira
Francesc Pujadas
M. Mar Freijo
Silvia Tur
Maite Martínez-Zabaleta
Pere Cardona Portela
Rocío Vera
Lucia Lebrato-Hernández
Juan F. Arenillas
Soledad Pérez-Sánchez
Joan Montaner
Pilar Delgado
Mar Hernández-Guillamon
spellingShingle Paula Marazuela
Anna Bonaterra-Pastra
Júlia Faura
Anna Penalba
Jesús Pizarro
Olalla Pancorbo
David Rodríguez-Luna
Carla Vert
Alex Rovira
Francesc Pujadas
M. Mar Freijo
Silvia Tur
Maite Martínez-Zabaleta
Pere Cardona Portela
Rocío Vera
Lucia Lebrato-Hernández
Juan F. Arenillas
Soledad Pérez-Sánchez
Joan Montaner
Pilar Delgado
Mar Hernández-Guillamon
Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage
Journal of Clinical Medicine
aquaporin 4
cerebral amyloid angiopathy
intracerebral hemorrhage
magnetic resonance imaging markers
functional outcome
author_facet Paula Marazuela
Anna Bonaterra-Pastra
Júlia Faura
Anna Penalba
Jesús Pizarro
Olalla Pancorbo
David Rodríguez-Luna
Carla Vert
Alex Rovira
Francesc Pujadas
M. Mar Freijo
Silvia Tur
Maite Martínez-Zabaleta
Pere Cardona Portela
Rocío Vera
Lucia Lebrato-Hernández
Juan F. Arenillas
Soledad Pérez-Sánchez
Joan Montaner
Pilar Delgado
Mar Hernández-Guillamon
author_sort Paula Marazuela
title Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage
title_short Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage
title_full Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage
title_fullStr Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage
title_full_unstemmed Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage
title_sort circulating aqp4 levels in patients with cerebral amyloid angiopathy-associated intracerebral hemorrhage
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2021-03-01
description Cerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in elderly patients. Growing evidence suggests a potential role of aquaporin 4 (AQP4) in amyloid-beta-associated diseases, including CAA pathology. Our aim was to investigate the circulating levels of AQP4 in a cohort of patients who had suffered a lobar ICH with a clinical diagnosis of CAA. AQP4 levels were analyzed in the serum of 60 CAA-related ICH patients and 19 non-stroke subjects by enzyme-linked immunosorbent assay (ELISA). The CAA–ICH cohort was divided according to the time point of the functional outcome evaluation: mid-term (12 ± 18.6 months) and long-term (38.5 ± 32.9 months) after the last ICH. Although no differences were found in AQP4 serum levels between cases and controls, lower levels were found in CAA patients presenting specific hemorrhagic features such as ≥2 lobar ICHs and ≥5 lobar microbleeds detected by magnetic resonance imaging (MRI). In addition, CAA-related ICH patients who presented a long-term good functional outcome had higher circulating AQP4 levels than subjects with a poor outcome or controls. Our data suggest that AQP4 could potentially predict a long-term functional outcome and may play a protective role after a lobar ICH.
topic aquaporin 4
cerebral amyloid angiopathy
intracerebral hemorrhage
magnetic resonance imaging markers
functional outcome
url https://www.mdpi.com/2077-0383/10/5/989
work_keys_str_mv AT paulamarazuela circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT annabonaterrapastra circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT juliafaura circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT annapenalba circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT jesuspizarro circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT olallapancorbo circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT davidrodriguezluna circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT carlavert circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT alexrovira circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT francescpujadas circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT mmarfreijo circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT silviatur circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT maitemartinezzabaleta circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT perecardonaportela circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT rociovera circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT lucialebratohernandez circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT juanfarenillas circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT soledadperezsanchez circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT joanmontaner circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT pilardelgado circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
AT marhernandezguillamon circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage
_version_ 1724234024873885696
spelling doaj-d7ced31b16e942579a4c22a7ac4a32612021-03-03T00:00:27ZengMDPI AGJournal of Clinical Medicine2077-03832021-03-011098998910.3390/jcm10050989Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral HemorrhagePaula Marazuela0Anna Bonaterra-Pastra1Júlia Faura2Anna Penalba3Jesús Pizarro4Olalla Pancorbo5David Rodríguez-Luna6Carla Vert7Alex Rovira8Francesc Pujadas9M. Mar Freijo10Silvia Tur11Maite Martínez-Zabaleta12Pere Cardona Portela13Rocío Vera14Lucia Lebrato-Hernández15Juan F. Arenillas16Soledad Pérez-Sánchez17Joan Montaner18Pilar Delgado19Mar Hernández-Guillamon20Neurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainStroke Unit, Department of Neurology, Vall d’Hebron Hospital, 08035 Barcelona, SpainStroke Unit, Department of Neurology, Vall d’Hebron Hospital, 08035 Barcelona, SpainNeuroradiology, Department of Radiology, Vall d’Hebron Hospital, 08035 Barcelona, SpainNeuroradiology, Department of Radiology, Vall d’Hebron Hospital, 08035 Barcelona, SpainDementia Unit, Neurology Department, Vall d’Hebron Hospital, 08035 Barcelona, SpainNeurovascular Group, Biocruces Health Research Institute, 48903 Barakaldo, SpainNeurology, Son Espases University Hospital, 07120 Balearic Islands, SpainDepartment of Neurology, Donostia University Hospital, 20080 San Sebastián, SpainDepartment of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, SpainStroke Unit, Department of Neurology, Ramon y Cajal University Hospital, 28034 Madrid, SpainStroke Unit, Virgen del Rocío University Hospital, 41013 Sevilla, SpainStroke Program, Department of Neurology, Hospital Clínico Universitario, 47003 Valladolid, SpainDepartment of Neurology, Virgen Macarena University Hospital, 41009 Sevilla, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainCerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in elderly patients. Growing evidence suggests a potential role of aquaporin 4 (AQP4) in amyloid-beta-associated diseases, including CAA pathology. Our aim was to investigate the circulating levels of AQP4 in a cohort of patients who had suffered a lobar ICH with a clinical diagnosis of CAA. AQP4 levels were analyzed in the serum of 60 CAA-related ICH patients and 19 non-stroke subjects by enzyme-linked immunosorbent assay (ELISA). The CAA–ICH cohort was divided according to the time point of the functional outcome evaluation: mid-term (12 ± 18.6 months) and long-term (38.5 ± 32.9 months) after the last ICH. Although no differences were found in AQP4 serum levels between cases and controls, lower levels were found in CAA patients presenting specific hemorrhagic features such as ≥2 lobar ICHs and ≥5 lobar microbleeds detected by magnetic resonance imaging (MRI). In addition, CAA-related ICH patients who presented a long-term good functional outcome had higher circulating AQP4 levels than subjects with a poor outcome or controls. Our data suggest that AQP4 could potentially predict a long-term functional outcome and may play a protective role after a lobar ICH.https://www.mdpi.com/2077-0383/10/5/989aquaporin 4cerebral amyloid angiopathyintracerebral hemorrhagemagnetic resonance imaging markersfunctional outcome